Skip to content

Confirmatory Clinical Study of Oxiplex

Confirmatory Clinical Study to Support the Effectiveness and Safety of Oxiplex for the Reduction of Pain and Symptoms Following Lumbar Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03433391
Enrollment
135
Registered
2018-02-14
Start date
2018-04-23
Completion date
2024-03-27
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herniated Lumbar Disk

Brief summary

This is a prospective, multi-center, randomized, controlled, patient and evaluator-blinded clinical study to assess the safety and effectiveness for the reduction of pain and symptoms following lumbar surgery.

Interventions

DEVICEOxiplex

Oxiplex is a clear, viscoelastic gel that is applied to operative site during lumbar spine surgery in order to coat the nerve root with a protective barrier.

OTHERSurgery Only

Single level partial discectomy as per standard of care procedures.

Sponsors

FzioMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
22 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Be between 22 and 70 years of age; 2. Have symptomatic posterior or posterolateral disc herniation at L4-L5 or L5-S1 with radiographic confirmation of nerve compression using MRI that requires partial surgical discectomy with or without laminotomy; 3. Have radiculopathy (e.g., decreased motor strength, sensory deficits, decreased reflexes) from specific nerve root distribution from L4 to S1 with positive straight leg raise (0-60 degrees); 4. Have at least one of the following: 1. At least six weeks of prior conservative treatment (e.g., physical therapy and/or use of anti-inflammatory medications, narcotics, and muscle relaxants at the manufacturer's recommended therapeutic dose); 2. The patient is experiencing intractable pain; or 3. There is substantial progression of loss of neurological function. 5. Have VAS leg pain score in the ipsilateral leg of at least 60mm on a 100mm scale; 6. Have VAS back pain score of at least 50mm on a 100mm scale; 7. Be appropriate for treatment using a posterior surgical approach; 8. Be likely to return for all follow-up visits; and 9. Be willing and able to provide Informed Consent for study participation.

Exclusion criteria

Pre-Operative

Design outcomes

Primary

MeasureTime frameDescription
Change in ipsilateral leg painPre-op; 6 weeks; 3 months; 6 monthsSubjects will complete a Visual Analogue Scale (VAS) for their ipsilateral leg pain at each visit. The VAS is a continuous and linear, scale ranging from No Pain to Worst Possible Pain.

Secondary

MeasureTime frameDescription
Change in back painPre-op; 6 weeks; 3 months; 6 monthsSubjects will complete a Visual Analogue Scale (VAS) for their back pain at each visit.The VAS is a continuous and linear, scale ranging from No Pain to Worst Possible Pain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026